These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 37047636)

  • 21. Interaction of Vitamin D with Peptide Hormones with Emphasis on Parathyroid Hormone, FGF23, and the Renin-Angiotensin-Aldosterone System.
    Latic N; Erben RG
    Nutrients; 2022 Dec; 14(23):. PubMed ID: 36501215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum fibroblast growth factor 23 and mineral metabolism in patients with euthyroid Graves' diseases: a case-control study.
    Lin CH; Chang CK; Shih CW; Li HY; Chen KY; Yang WS; Tsai KS; Wang CY; Shih SR
    Osteoporos Int; 2019 Nov; 30(11):2289-2297. PubMed ID: 31384956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: updating the "trade-off" hypothesis.
    Gutiérrez OM
    Clin J Am Soc Nephrol; 2010 Sep; 5(9):1710-6. PubMed ID: 20507957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of vitamin D replacement therapy in serum FGF23 concentration in children with myelomeningocele compared with healthy children - a preliminary study.
    Bagińska J; Liszewska A; Korzeniecka-Kozerska A
    J Pediatr Endocrinol Metab; 2019 Nov; 32(11):1259-1264. PubMed ID: 31465293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Skeletal secretion of FGF-23 regulates phosphate and vitamin D metabolism.
    Quarles LD
    Nat Rev Endocrinol; 2012 Jan; 8(5):276-86. PubMed ID: 22249518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone-kidney axis in systemic phosphate turnover.
    Razzaque MS
    Arch Biochem Biophys; 2014 Nov; 561():154-8. PubMed ID: 24997362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osteo-renal regulation of systemic phosphate metabolism.
    Razzaque MS
    IUBMB Life; 2011 Apr; 63(4):240-7. PubMed ID: 21438115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beyond mineral metabolism, is there an interplay between FGF23 and vitamin D in innate immunity?
    Bacchetta J; Salusky IB; Hewison M
    Pediatr Nephrol; 2013 Apr; 28(4):577-82. PubMed ID: 23117582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The bone is the major source of high circulating intact fibroblast growth factor-23 in acute murine polymicrobial sepsis induced by cecum ligation puncture.
    Bayer J; Vaghela R; Drechsler S; Osuchowski MF; Erben RG; Andrukhova O
    PLoS One; 2021; 16(5):e0251317. PubMed ID: 33989306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibroblast growth factor 23 and bone metabolism in children with chronic kidney disease.
    van Husen M; Fischer AK; Lehnhardt A; Klaassen I; Möller K; Müller-Wiefel DE; Kemper MJ
    Kidney Int; 2010 Jul; 78(2):200-6. PubMed ID: 20407479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coupling fibroblast growth factor 23 production and cleavage: iron deficiency, rickets, and kidney disease.
    Wolf M; White KE
    Curr Opin Nephrol Hypertens; 2014 Jul; 23(4):411-9. PubMed ID: 24867675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism.
    Shimada T; Kakitani M; Yamazaki Y; Hasegawa H; Takeuchi Y; Fujita T; Fukumoto S; Tomizuka K; Yamashita T
    J Clin Invest; 2004 Feb; 113(4):561-8. PubMed ID: 14966565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibroblast Growth Factor 23 and Risk of CKD Progression in Children.
    Portale AA; Wolf MS; Messinger S; Perwad F; Jüppner H; Warady BA; Furth SL; Salusky IB
    Clin J Am Soc Nephrol; 2016 Nov; 11(11):1989-1998. PubMed ID: 27561289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Klotho Lacks an FGF23-Independent Role in Mineral Homeostasis.
    Andrukhova O; Bayer J; Schüler C; Zeitz U; Murali SK; Ada S; Alvarez-Pez JM; Smorodchenko A; Erben RG
    J Bone Miner Res; 2017 Oct; 32(10):2049-2061. PubMed ID: 28600880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FGF23 and mineral metabolism in the early post-renal transplantation period.
    Wesseling-Perry K; Pereira RC; Tsai E; Ettenger R; Jüppner H; Salusky IB
    Pediatr Nephrol; 2013 Nov; 28(11):2207-15. PubMed ID: 23852336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The interrelation between FGF23 and glucose metabolism in humans.
    Ursem SR; Vervloet MG; Büttler RM; Ackermans MT; Oosterwerff MM; Eekhoff EMV; Lips P; Serlie MJ; la Fleur SE; Heijboer AC
    J Diabetes Complications; 2018 Sep; 32(9):845-850. PubMed ID: 29996975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Vascular Calcification - Pathological Mechanism and Clinical Application - . Regulation of mineral metabolism and mineralization by FGF23].
    Fukumoto S
    Clin Calcium; 2015 May; 25(5):687-91. PubMed ID: 25926572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ergocalciferol treatment and aspects of mineral homeostasis in patients with chronic kidney disease stage 4-5.
    Gravesen E; Hofman-Bang J; Lewin E; Olgaard K
    Scand J Clin Lab Invest; 2013 Mar; 73(2):107-16. PubMed ID: 23281842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dietary phosphate restriction suppresses phosphaturia but does not prevent FGF23 elevation in a mouse model of chronic kidney disease.
    Zhang S; Gillihan R; He N; Fields T; Liu S; Green T; Stubbs JR
    Kidney Int; 2013 Oct; 84(4):713-21. PubMed ID: 23698235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Burosumab in X-linked hypophosphatemia and perspective for chronic kidney disease.
    Balani S; Perwad F
    Curr Opin Nephrol Hypertens; 2020 Sep; 29(5):531-536. PubMed ID: 32701599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.